Skip to content
No results
  • About Us
  • Contact Us
  • Disclaimer
  • Event Venues
  • Events and Conferences
  • Home
  • Organizer Dashboard
  • Organizer Dashboard
  • Privacy Policy
  • Submit Organizer Form
  • Submit Organizer Form
  • Submit Venue Form
  • Submit Venue Form
  • Subscribe
  • Terms and Conditions
  • Venue Dashboard
  • Venue Dashboard
  • About Us
  • Contact Us
The Pharma Data

  • News
  • Press Releases
  • Research
  • Business
  • Regulatory
  • Events and Conferences
The Pharma Data
  • Press Releases

Salubris Biotherapeutics Reports Positive Interim Data from Phase 2 Heart Failure Trial of JK07

  • The Pharma Data
  • January 27, 2025

Salubris Biotherapeutics Announces Positive Interim Data from Phase 2 Trial of JK07 in Heart Failure Salubris Biotherapeutics a clinical-stage biotechnology company focused on developing innovative biologic therapies, has announced promising…

Read MoreSalubris Biotherapeutics Reports Positive Interim Data from Phase 2 Heart Failure Trial of JK07
  • Regulatory

Roche Gets FDA Clearance for CLIA-Waived STI Point-of-Care Tests

  • The Pharma Data
  • January 24, 2025

Roche Receives FDA Clearance for CLIA-Waived STI Point-of-Care Tests Roche has announced a major milestone in the realm of sexual health diagnostics. The U.S. Food and Drug Administration (FDA) has…

Read MoreRoche Gets FDA Clearance for CLIA-Waived STI Point-of-Care Tests
  • Research

Sarclisa Approved in EU for Treating Transplant-Ineligible Newly Diagnosed Multiple Myeloma

  • The Pharma Data
  • January 24, 2025

European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP), the EU has approved Sarclisa in combination with a standard-of-care regimen—bortezomib, lenalidomide, and dexamethasone (VRd)—for the treatment of…

Read MoreSarclisa Approved in EU for Treating Transplant-Ineligible Newly Diagnosed Multiple Myeloma
  • News

Phase 2 Trial: Cytokinetics Launches AMBER-HFpEF Study of CK-586 in Symptomatic HFpEF

  • The Pharma Data
  • January 22, 2025

Introduction: Cytokinetics Advances CK-586 into Phase 2 Trial Cytokinetics, Incorporated a leading biopharmaceutical company, has announced that enrollment is now open for AMBER-HFpEF, a pivotal Phase 2 clinical trial evaluating…

Read MorePhase 2 Trial: Cytokinetics Launches AMBER-HFpEF Study of CK-586 in Symptomatic HFpEF
  • Press Releases

BrainChild Bio Receives Prestigious G-Rex® Grant from ScaleReady

  • The Pharma Data
  • January 22, 2025

BrainChild Bio Receives Recognition for Innovation in Cell Therapy ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation, and CellReady, has announced that BrainChild Bio has been awarded a $300,000…

Read MoreBrainChild Bio Receives Prestigious G-Rex® Grant from ScaleReady
  • Press Releases

WHO Responds to U.S. Announcement of Withdrawal Intent

  • The Pharma Data
  • January 22, 2025

WHO Expresses Regret Over U.S. Withdrawal Announcement The World Health Organization (WHO) has expressed deep regret over the announcement that the United States intends to withdraw from the Organization. The…

Read MoreWHO Responds to U.S. Announcement of Withdrawal Intent
  • Press Releases

Poxel to Gain Increased Royalties from Sumitomo Pharma for TWYMEEG Sales in Japan

  • The Pharma Data
  • January 21, 2025

Poxel Achieves Milestone with TWYMEEG® Sales in Japan, Secures Royalties and Sales-Based Payments Poxel, a clinical-stage biopharmaceutical company focused on innovative treatments for chronic serious diseases with metabolic pathophysiology—including metabolic…

Read MorePoxel to Gain Increased Royalties from Sumitomo Pharma for TWYMEEG Sales in Japan
  • News

Poxel Secures Patent in China for Imeglimin Use in Type-2 Diabetic Patients with Renal Impairment

  • The Pharma Data
  • January 21, 2025

Poxel Advances Global Strategy with Key Patent for Imeglimin in China Expanding Innovative Treatments for Chronic Metabolic Diseases Poxel, a clinical-stage biopharmaceutical company focused on developing cutting-edge treatments for chronic…

Read MorePoxel Secures Patent in China for Imeglimin Use in Type-2 Diabetic Patients with Renal Impairment
  • Business

Aseptic Filling Machine Market Forecast to 2035 Key Players Profiled

  • The Pharma Data
  • January 21, 2025

Aseptic Filling Machine Market: Industry Trends and Global Forecasts to 2035 The global market for aseptic filling machines has witnessed remarkable growth over recent years, driven by advancements in pharmaceutical…

Read MoreAseptic Filling Machine Market Forecast to 2035 Key Players Profiled
  • News

Gaza Ceasefire Brings Hope, but Health System Challenges Remain

  • The Pharma Data
  • January 21, 2025

WHO Welcomes Gaza Ceasefire but Highlights Immense Health Challenges Ahead The World Health Organization (WHO) has welcomed the Gaza ceasefire and the associated hostage and prisoner release deal, bringing a…

Read MoreGaza Ceasefire Brings Hope, but Health System Challenges Remain
  • Business

Leaps by Bayer Launches Global Survey on Breakthrough Tech Attitudes

  • The Pharma Data
  • January 21, 2025

Global Survey Explores Public Sentiment on Breakthrough Technologies As Global Survey leaders convene for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm…

Read MoreLeaps by Bayer Launches Global Survey on Breakthrough Tech Attitudes
  • Research

Experimental Breast Cancer Drug Shows Potential to Treat Certain Blood Cancers

  • The Pharma Data
  • January 20, 2025

Two groundbreaking studies conducted by researchers at Washington University School of Medicine in St. Louis have identified a promising approach to halting the progression of several forms of blood cancer…

Read MoreExperimental Breast Cancer Drug Shows Potential to Treat Certain Blood Cancers
PrevNext
UK Biotech Day
Global Clinical Trial Supply Forum 2026 I Frankfurt, Germany

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • Niagen Bioscience Launches Niagen Plus Telehealth Platform with New At-Home Injection Kit Offering
  • Alnylam Pharmaceuticals to Showcase New Analyses at Heart Failure 2026 Highlighting Consistent Clinical Profile of Vutrisiran in ATTR-CM
  • Spruce Biosciences Bolsters Commercial Leadership with Appointments of Brian Walls and Darren Johnson
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.